🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a single arm, nonrandomized, single center clinical study to invest...
Status
Unknown
Location
Hai-Tao Zhao
Start Date
2021-10-01
Trial ID
NCT05048017
Treatments Being Tested
The purpose of this study is to find out what effects the combination of re...
Status
Completed
Location
BC Cancer Agency - Vancouver Cancer Centre
Start Date
2016-08
Trial ID
NCT02651415
Treatments Being Tested
This is an observational study using data that has been collected from part...
Status
Completed
Location
Many locations
Start Date
2023-04-24
Trial ID
NCT05839951
Treatments Being Tested
The purpose of this study was to determine if ruxolitinib, in combination w...
Status
Terminated
Location
Multiple Locations
Start Date
2014-03
Trial ID
NCT02119676
Treatments Being Tested
It is estimated that over 50% of HCC cases worldwide are related to chronic...
Status
Recruiting
Location
Humanity & Health Research Centre
Start Date
2019-05-02
Trial ID
NCT03899428
Treatments Being Tested
This is an interventional, randomized open-label, parallel-group, multicent...
Status
Unknown
Location
The First Hospital of China Medical University
Start Date
2019-07
Trial ID
NCT04008511
Treatments Being Tested
The purpose of this study is to assess the safety and efficacy of lenvatini...
Status
Completed
Location
Pacific Cancer Care ( Site 0031)
Start Date
2021-03-29
Trial ID
NCT04776148
Treatments Being Tested
This study will evaluate the safety, tolerability, pharmacokinetics (PK), a...
Status
Terminated
Location
Honor Health Research Institute
Start Date
2023-04-04
Trial ID
NCT05731947
Treatments Being Tested
The purpose of this study is to assess the safety and efficacy of coformula...
Status
Completed
Location
Georgetown University Hospital ( Site 1148)
Start Date
2021-11-10
Trial ID
NCT05064059
Treatments Being Tested
The purpose of this study is to provide continued supply of ruxolitinib alo...
Status
Active Not Recruiting
Location
UCLA Healthcare Hematology-Oncology
Start Date
2016-11-30
Trial ID
NCT02955940
Treatments Being Tested